Category: Trade Groups and Think Tanks
The U.S. cannot continue on its present financial trajectory and continue to undermine small businesses. Karen Kerrigan joins Jim Blasingame to report on Europe as an economic forecaster for the U.S. and the dangers of not addressing the national debt.
Small businesses are working hard to improve the Greece’s financial crisis. Karen Kerrigan joins Jim Blasingame to report on the resilience, persistence and optimism of small businesses in Greece.
Should U.S. drug companies benefit from European testing results? Avik Roy joins Jim Blasingame to compare the U.S. and European drug testing systems to bring new drugs to the market, plus the added costs of litigation.
Can FDA approval for new drugs become less onerous? Avik Roy joins Jim Blasingame to report on the high costs of FDA-required clinical trials and the advantages of an accelerated trial program.
The cost of taking a new drug to market is over ten times more today than in 1975. Avik Roy joins Jim Blasingame to report on the cost of complying with current FDA regulations is making new drug development prohibitive.
Would investors want to know if publicly traded companies abused small business vendors? Jim Copland joins Jim Blasingame to discuss how small businesses may be able to use the proxy process to expose abuses by big businesses toward small business vendors.
Do certain interest groups, including unions, use the proxy process to further their own agendas? Jim Copland joins Jim Blasingame to discuss how unions may abuse the shareholder proxy process by having a disproportionate affect on a company’s governance.
Why aren't small businesses hiring more? Bill Dunkelberg joins Jim Blasingame with the NFIB Small Business Index that indicates a continuing problem the growth elements of hiring and capital expenditures and why this is happening.
The national debt, tax policies and other issues are taking a toll on small business optimism? NFIB’s Bill Dunkelberg joins Jim Blasingame to report small business optimism has turned negative, possibly from continuing economic and political uncertainty.
Presidents use regulatory agencies to subvert the legislative process. Giovanni Coratolo joins Jim Blasingame with specific examples of how the Obama administration has used the EPA and other agencies to go around Congress.
Browse by category
3rd Ingredient™ (54)
Business Acquisition (191)
Business Planning (610)
Customer Care (726)
Economy: Nation, Global (1919)
Financial Planning (278)
Franchising, Licensing (106)
Future Thinking (417)
Government, Politics (2092)
Home-Based, Teleworking (427)
Human Resources (993)
Innovation, Creativity (538)
Intellectual Property (106)
Leadership, Ethics, Trust (1443)
Management Fundamentals (2429)
Sales, Sales Management (1035)
Start Up (640)
Technology - General (515)
Training, e-Learning (109)